# 68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma

> **NCT06911021** · NA · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 20 (estimated)

## Conditions studied

- Pancreatic Adenocarcinoma
- PET / CT
- FAPI
- Surgical Oncology
- Molecular Imaging

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-FAPI-46 PET/CT

## Key facts

- **NCT ID:** NCT06911021
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06911021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06911021, "68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06911021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*